Oraldent is proud to present the Xerostom range, a clinically validated lineup of oral care products, at the upcoming Oncology Professional Care 2024, Excel London. These products are specifically designed to combat dry mouth, a frequent and debilitating side effect experienced by over 75% of advanced cancer patients undergoing treatments such as chemotherapy and radiotherapy.

The Xerostom range includes toothpaste, mouthwash, saliva gel, mucosa gel, spray, and pastilles, each formulated to increase salivary flow by up to 200%, providing essential relief and enhancing the quality of life for patients. Dry mouth in cancer care can significantly impact eating, speaking, and swallowing, increasing the risk of dental decay and affecting patient comfort and health.

Free from sugar, acids, strong flavours, detergents, and SLS, the Xerostom products are tailored to meet the needs of those with heightened sensitivity due to cancer treatments, ensuring effective relief without irritation.

Oraldent invites all visitors to explore the benefits of the Xerostom range at Stand F40.

For more information, samples or to place an order please contact Oraldent at 01480 862080, email info@oraldent.co.uk or visit oraldent.co.uk.